PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2026New England Journal of Medicine0 citations

Aspirin after PCI in Acute Coronary Syndromes

View Full Paper
MSMaria-Luisa StraßmeirUBUlrike BaumerANAlexander Niessner

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Straßmeir et al. (2026) studied this question.

synapsesocial.com/papers/6a025c9dedf6f481385947eehttps://doi.org/10.1056/nejmc2518964
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS2017 · 3,010 citations
  2. 2Ticagrelor with or without Aspirin in High-Risk Patients after PCI2019 · 1,033 citations
  3. 3Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEO-MINDSET trial2025 · 12 citations
  4. 4Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI2025 · 11 citations
  5. 5Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes2025 · 74 citations